Krystal Biotech (KRYS) Return on Sales: 2024-2025
Historic Return on Sales for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to 0.53%.
- Krystal Biotech's Return on Sales rose 32.00% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 32.00%. This contributed to the annual value of 0.31% for FY2024, which is 9.00% up from last year.
- Per Krystal Biotech's latest filing, its Return on Sales stood at 0.53% for Q3 2025, which was up 30.51% from 0.41% recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's Return on Sales registered a high of 0.64% during Q2 2024, and its lowest value of 0.22% during Q3 2024.
- Its 2-year average for Return on Sales is 0.42%, with a median of 0.41% in 2025.
- Examining YoY changes over the last 5 years, Krystal Biotech's Return on Sales showed a top increase of 32bps in 2025 and a maximum decrease of 23bps in 2025.
- Quarterly analysis of 2 years shows Krystal Biotech's Return on Sales stood at 0.31% in 2024, then soared by 32bps to 0.53% in 2025.
- Its last three reported values are 0.53% in Q3 2025, 0.41% for Q2 2025, and 0.37% during Q1 2025.